Skip to main content

FDA recall, , Moderate risk

Tychasis Coats Aloe Lotion, Creme and Liniment

Tychasis Coats Aloe Lotion, Creme and Liniment have failed stability specifications.

What happened

BioMed Laboratories, LLC of Dallas, Texas voluntarily recalled Tychasis Coats Aloe Lotion, Tychasis Coats Aloe Liniment, and Tychasis Coats Aloe Creme because the products failed stability specifications, including viscosity and appearance results that did not align with established specifications. The recall began October 15, 2026, and was added to the FDA's Enforcement Report on November 2, 2026.

The products were manufactured for Tychasis Corporation of Dallas, TX 75227, and distributed in Texas only. The lotion and liniment came in 0.5 oz sample bottles, 8 oz bottles, and 33 oz bottles; the creme came in 4 oz and 16 oz jars. Customers were notified by letter.

3 photos

What to do

The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

3 products

Affected if its lot code and NDC are listed under that product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Tychasis Coats Aloe Lotion (Allantoin 0.5%)

    NDC
    • 70211-704-08
    • 70211-704-33
    Lot code
    • 011636
    • 0001882604
    • 0001987649
    • 008943
    • 0001893936
  2. Tychasis Coats Aloe Liniment (Methyl salicylate 10%)

    NDC
    • 70211-704-08
    • 70211-704-33
    Lot code
    • 0.5
    • 0001882607
    • 0001882605
    • 0001916439
    • 0001882606
  3. Tychasis Coats Aloe Creme (Allantoin 0.5%)

    NDC
    • 70211-703-04
    • 70211-703-16
    Lot code
    • 0002011787
    • 0001932354
    • 0002049590

Recall details

Posted by FDA
Recall began
Status
Open
Recalled by
BioMed Laboratories, LLC.Dallas, Texas
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100153
Recall numbers
D-0159-2027 to D-0161-2027
Recall type
Voluntary: Firm initiated
How the company first told customers
Letter

All recalls from BioMed Laboratories, LLC.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. BioMed Laboratories began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)